ARCHIVES

Wynder’s Low Fat Adjuvant Breast Cancer Study Finally Funded

This article is from The Cancer Letter archive.

Vol. 14 No. 41 | October 21, 1988

Download PDF Visit The Full Archive

Related Articles

CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome

April 22, 1983

Draft FY 1993 Bypass Budget Seeks $2.7 Billion, Stabilization Of Groups, Centers, And Prevention

May 10, 1991

ASCO/AUA Suggest 5-ARIs To Cut Prostate Cancer Risk

February 27, 2009

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

Drug Combination Tested For B.C. Brain Metastases

January 25, 2008